For this article, qualitative interviews were conducted with heavy drinkers to explore their experiences of discussing alcohol use with their general practitioner.

This article reviews nutritional considerations in patients who drink at risky levels or have alcohol dependence. It aims to enhance GPs’ awareness of nutritional considerations in this patient group.

GPs play an important ongoing role in supporting gifted children and developing a course of action that helps ensure their optimum development so they can fulfil their potential.

Olfactory impairment is a common condition, particularly in the geriatric population, that can be underrecognised as a result of clinician and patient unfamiliarity.

Patients prescribed high doses of opioids need to be managed appropriately to reduce risks of morbidity and mortality.

Respiratory tract and sleep disorders – including obstructive sleep apnoea, difficult-to-treat asthma in adults, and insomnia – are commonly encountered in general practice.

The connection between sleep and health has been recognised for centuries, but it is only relatively recently that the treatment of sleep disorders has developed as a medical specialty.

Medicinal cannabis is generally well tolerated, but the science related to its potential adverse effects is in its infancy.

Growing evidence shows that lifestyle interventions are an effective component of management for patients with mental illness to improve mental health, physical health and quality of life.

Medicare Benefits Schedule rules regarding sleep study eligibility have recently changed and incorporate validated questionnaires of obstructive sleep apnoea risk and subjective sleepiness.

Despite recent exponential growth in research on familial hypercholesterolaemia, there remains a general lack of public and health professional awareness about the disorder.

Although myeloproliferative neoplasms are rare illnesses, the general practitioner is well placed to identify suspicious features and initiate investigations and referral.

On average, 47% of patients with COVID-19 self-report an olfactory disorder, although the inaccuracy of self-reporting means this figure may be higher.